The Food and Drug Administration identified 43 new drug and biological product shortages in 2020, down from 51 in 2019, and 86 ongoing shortages from prior years, according to the agency’s latest annual report to Congress on the issue.

“Although the number of new drug shortages has declined since 2011 as a result of work by many groups, including FDA, shortages continue to pose a real challenge to public health,” the report notes. “This is especially the case when the shortage involves a critical drug to treat cancer, to provide parenteral nutrition, or to address another serious medical condition, such as a shortage of blood pressure medications. Although there has been a leveling off in new shortages over the past few years, CY 2020 has been a challenging year for shortages. FDA continues to see the residual effects from the closing of two manufacturing facilities in 2017 and 2018 by major drug manufacturers for remediation purposes, which resulted in the loss of the manufacturing capacity needed for the supplies of numerous drugs. In addition, the COVID-19 pandemic has greatly affected the pharmaceutical supply chain in CY 2020, such as through the increase in demand for many drug products.”

 

Related News Articles

Headline
To help hospitals and health systems meet demand during the current surge in respiratory illnesses for fever-reducing products to treat pediatric patients and…
Headline
The Department of Health and Human Services’ Office on Trafficking in Persons last week issued a request for information on forced labor in health care supply…
Perspective
We all know that the COVID-19 pandemic has exacerbated many longstanding challenges facing the health care field. One of the most alarming developments that is…
Headline
The Department of Defense, General Services Administration, and National Aeronautics and Space Administration today released a proposed rule intended to…
Headline
Non-traditional producers used additive manufacturing — also known as 3D printing — to deliver an estimated 38 million face shield parts, 12 million nasal…
Headline
The Department of Health and Human Services will establish a public-private consortium to increase U.S. production of essential medicines and active…